Zanella VG, Wagner VP, Schmidt TR, Thieme S, Correa C, Fonseca FP, et al. Salivary gland cancer in Southern Brazil: a prognostic study of 107 cases. Med Oral Patol Oral Cir Bucal. 2021 May 1;26 (3):e393-403.


doi:10.4317/medoral.24248

https://dx.doi.org/doi:10.4317/medoral.24248


1. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68:394-424.

https://doi.org/10.3322/caac.21492

PMid:30207593 

2. Pillai RK, Jayasree K. Rare cancers: Challenges & issues. Indian J Med Res. 2017;145:17-27.

https://doi.org/10.4103/ijmr.IJMR_915_14

PMid:28574010 PMCid:PMC5460568

3. Rito M, Fonseca I. Salivary gland neoplasms: Does morphological diversity reflect tumor heterogeneity. Pathobiology. 2018;85:85-95.

https://doi.org/10.1159/000479070

PMid:28930752 

4. Seethala RR, Stenman G. Update from the 4th Edition of the World Health Organization Classification of Head and Neck Tumours: Tumors of the Salivary Gland. Head Neck Pathol. 2017;11:55-67.

https://doi.org/10.1007/s12105-017-0795-0

PMid:28247227 PMCid:PMC5340736

5. Ito FA, Ito K, Vargas PA, de Almeida OP, Lopes MA. Salivary gland tumors in a Brazilian population: a retrospective study of 496 cases. Int J Oral Maxillofac Surg. 2005;34:533-6.

https://doi.org/10.1016/j.ijom.2005.02.005

PMid:16053874 

6. Fonseca FP, Carvalho MV, de Almeida OP, Rangel ALCA, Takizawa MCH, Bueno AG, et al. Clinicopathologic analysis of 493 cases of salivary gland tumors in a Southern Brazilian population. Oral Surg Oral Med Oral Pathol Oral Radiol. 2012;114:230-9.

https://doi.org/10.1016/j.oooo.2012.04.008

PMid:22769409 

7. Kara MI, Göze F, Ezirganli S, Polat S, Muderris S, Elagoz S. Neoplasms of the salivary glands in a Turkish adult population. Med Oral Patol Oral Cir Bucal. 2010;15:880-5.

https://doi.org/10.4317/medoral.15.e880

PMid:20526249 

8. Luksic I, Virag M, Manoilovic S, Macan D. Salivary gland tumours: 25 years of experience from a single institution in Croatia. J Craniomaxillofac Surg. 2012; 40:75-81.

https://doi.org/10.1016/j.jcms.2011.05.002

PMid:21641811 

9. Vasconcelos AC, Nör F, Meurer L, Salvadori G, Souza LB, Vargas PA, et al. Clinicopathological analysis of salivary gland tumors over a 15-year period. Braz Oral Res. 2016;30:S1806-83242016000100208.

https://doi.org/10.1590/1807-3107BOR-2016.vol30.0002

PMid:26676198

10. Lydiatt W, O'Sullivan B, Patel S. Major Changes in Head and Neck Staging for 2018. Am Soc Clin Oncol Educ Book. 2018;38:505-14.

https://doi.org/10.1200/EDBK_199697

PMid:30231400 

11. Goode RK, Auclair PL, Ellis GL. Mucoepidermoid carcinoma of the major salivary glands: clinical and histopathologic analysis of 234 cases with evaluation of grading criteria. Cancer. 1998;82:1217-24.

https://doi.org/10.1002/(SICI)1097-0142(19980401)82:7<1217::AID-CNCR2>3.0.CO;2-C

PMid:9529011

12. Pérez-de-Oliveira ME, Wagner VP, Araújo ALD, Martins MD, Santos-Silva AR, Bingle L, et al. Prognostic value of CRTC1-MAML2 translocation in salivary mucoepidermoid carcinoma: Systematic review and meta-analysis. J Oral Pathol Med. 2020; 49:386-94.

https://doi.org/10.1111/jop.12970

PMid:31661572 

13. Fonseca FP, Basso MP, Mariano FV, Kovalski LP, Lopes MA, Martins MD, et al. Vascular endothelial growth factor immunoexpression is increased in malignant salivary gland tumors. Ann Diagn Pathol. 2015;19:169-74.

https://doi.org/10.1016/j.anndiagpath.2015.03.010

PMid:25900273 

14. Wagner VP, Martins MD, Guimaraes DM, Vasconcelos AC, Meurer L, Vargas PA, et al. Reduced chromatin acetylation of malignant salivary gland tumors correlates with enhanced proliferation. J Oral Pathol Med. 2017;46:792-97.

https://doi.org/10.1111/jop.12557

PMid:28161900 

15. Fonseca FP, Macedo CCS, Dos Santos Costa SF, Leme AFP, Rodrigues RR, Pontes HAR, et al. Mass spectrometry-based proteome profile may be useful to differentiate adenoid cystic carcinoma from polymorphous adenocarcinoma of salivary glands. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019;128:639-50.

https://doi.org/10.1016/j.oooo.2019.07.016

PMid:31494112 

16. Wagner VP, Martins MA, Martins MD, Warner KA, Webber LP, Squarize CH, et al. Overcoming adaptive resistance in mucoepidermoid carcinoma through inhibition of the IKK-β/IκBα/NFκB axis. Oncotarget. 2016;7:73032-44.

https://doi.org/10.18632/oncotarget.12195

PMid:27682876 PMCid:PMC5341961

17. Wagner VP, Martins MD, Martins MAT, Almeida LO, Warner KA, Nör JE, et al. Targeting histone deacetylase and NFκB signaling as a novel therapy for Mucoepidermoid Carcinomas. Sci Rep. 2018;8:2065.

https://doi.org/10.1038/s41598-018-20345-w

PMid:29391537 PMCid:PMC5794736

18. Vargas PA, Gerhard R, Araújo Filho VJ, de Castro IV. Salivary gland tumors in a Brazilian population: a retrospective study of 124 cases. Rev Hosp Clin Fac Med Sao Paulo. 2002;57:271-6.

https://doi.org/10.1590/S0041-87812002000600005

PMid:12612759 

19. Bjørndal K, Larsen SR, Therkildsen MH, Kristensen CA, Charabi B, Andersen E, et al. Does age affect prognosis in salivary gland carcinoma patients? A national Danish study. Acta Oncol. 2016;55:19-22.

https://doi.org/10.3109/0284186X.2015.1114671

PMid:26825002 

20. Bello IO, Salo T, Dayan D, Tervahauta E, Almangoush A, Schnaiderman-Shapiro A, et al. Epithelial salivary gland tumors in two distant geographical locations, Finland (Helsinki and Oulu) and Israel (Tel Aviv): a 10-year retrospective comparative study of 2,218 cases. Head Neck Pathol. 2012;6:224-31.

https://doi.org/10.1007/s12105-011-0316-5

PMid:22228070 PMCid:PMC3370031

21. Fonseca FP, Sena Filho M, Altemani A, Speight PM, Vargas PA. Molecular signature of salivary gland tumors: potential use as diagnostic and prognostic marker. J Oral Pathol Med. 2016;45:101-10.

https://doi.org/10.1111/jop.12329

PMid:25990369 

22. Lin HH, Limesand KH, Ann DK. Current State of Knowledge on Salivary Gland Cancers. Crit Rev Oncog. 2018;23:139-51.

https://doi.org/10.1615/CritRevOncog.2018027598

PMid:30311570 PMCid:PMC6415949

23. Sultan I, Rodriguez-Galindo C, Al-Sharabati S, Guzzo M, Casanova M, Ferrari A. Salivary gland carcinomas in children and adolescents: a population-based study, with comparison to adult cases. Head Neck. 2011;33:1476-81.

https://doi.org/10.1002/hed.21629

PMid:21928420 

24. Cockerill CC, Gross BC, Contag S, Rein S, Moore EJ, Olsen KD, et al. Pediatric malignant salivary gland tumors: 60 year follow up. Int J Pediatr Otorhinolaryngol. 2016;88:1-6.

https://doi.org/10.1016/j.ijporl.2016.05.021

PMid:27497376 

25. McHugh CH, Roberts DB, El-Naggar AK, Hanna EY, Garden AS, Kies MS, et al. Prognostic factors in mucoepidermoid carcinoma of the salivary glands. Cancer. 2012;118:3928-36.

https://doi.org/10.1002/cncr.26697

PMid:22180391 

26. Ju J, Li Y, Chai J, Ma C, Ni Q, Shen Z, et al. The role of perineural invasion on head and neck adenoid cystic carcinoma prognosis: a systematic review and meta-analysis. Oral Surg Oral Med Oral Pathol Oral Radiol. 2016;122:691-701.

https://doi.org/10.1016/j.oooo.2016.08.008

PMid:27727107 

27. Pires FR, de Almeida OP, de Araújo VC, Kowalski LP. Prognostic factors in head and neck mucoepidermoid carcinoma. Arch Otolaryngol Head Neck Surg. 2004;130:174-80.

https://doi.org/10.1001/archotol.130.2.174

PMid:14967746 

28. da Cruz Perez DE, de Abreu Alves F, Nobuko Nishimoto I, de Almeida OP, Kowalski LP. Prognostic factors in head and neck adenoid cystic carcinoma. Oral Oncol. 2006;42:139-46.

https://doi.org/10.1016/j.oraloncology.2005.06.024

PMid:16249115